International Clinical Trial: Efficacy and Safety of Genakumab Injection in the Treatment of Gouty Arthritis: A Randomized, Double-Blind, Double-Dummy, Active-Controlled, Multicenter Phase III Clinical Trial Injection in the Treatment of Gouty Arthritis: A Randomized, Double-Blind, Double-Dummy, Active-Controlled, Multicenter Phase III Clinical Trial

Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600128798) titled 'Efficacy and Safety of Genakumab Injection in the Treatment of Gouty Arthritis: A Randomized, Double-Blind, Double-Dummy, Active-Controlled, Multicenter Phase III Clinical Trial Injection in the Treatment of Gouty Arthritis: A Randomized, Double-Blind, Double-Dummy, Active-Controlled, Multicenter Phase III Clinical Trial' on July 26.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Huashan Hospital, Fudan University

Condition: Gouty Arthritis

Intervention: Treatment group:Genakumab for Injection 200mg sc. + Compound Betamethasone Injection matching placebo 1ml im.

Recruitment Status...